Antiherpes activity of 5-(2-bromoethyl)-2'-deoxyuridine.
D000212:Acyclovir / Q000494:pharmacology; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives* / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D003587:Cytomegalovirus / Q000187:drug effects / Q000235:genetics / Q000254:growth & development; D004279:DNA, Viral / Q000096:biosynthesis; D004259:DNA-Directed DNA Polymerase; D006801:Humans; D007065:Idoxuridine / Q000494:pharmacology; D009154:Mutation; D010746:Phosphonoacetic Acid / Q000494:pharmacology; D010766:Phosphorylation; D018139:Simplexvirus / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development; D013937:Thymidine Kinase / Q000378:metabolism; D010948:Viral Plaque Assay
D000998:Antiviral Agents; D004279:DNA, Viral; C047369:5-(2-bromoethyl)-2'-deoxyuridine; D013937:Thymidine Kinase; D004259:DNA-Directed DNA Polymerase; D001973:Bromodeoxyuridine; D007065:Idoxuridine; D010746:Phosphonoacetic Acid; D000212:Acyclovir